Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 2:2018:2784537.
doi: 10.1155/2018/2784537. eCollection 2018.

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis

Bei Li  1 , Chuan Zhang  1 , Yu-Tao Zhan  1
Affiliations
Review

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis

Bei Li et al. Can J Gastroenterol Hepatol. .

Abstract

Cirrhosis is the common end stage of a number of chronic liver conditions and a significant cause of morbidity and mortality. With the growing epidemic of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide and will become one of the leading causes of cirrhosis. Increased awareness and understanding of NAFLD cirrhosis are essential. To date, there has been no published systematic review on NAFLD cirrhosis. Thus, this article reviews recent studies on the epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis of NAFLD cirrhosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposal of diagnostic algorithm for classification of patients affected by NAFLD. NAFLD: nonalcoholic fatty liver disease; NFS: NAFLD fibrosis score; TE: transient elastography; LSE: liver stiffness measurement; kPa: kilopascal.
See this image and copyright information in PMC

References

    1. de la Garza R. G., Morales-Garza L. A., Martin-Estal I., Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and cirrhosis establishment. Journal of Clinical Medicine Research. 2017;9(4):G233–G247. doi: 10.14740/jocmr2761w. - DOI - PMC - PubMed
    1. Stasi C., Silvestri C., Voller F., Cipriani F. Epidemiology of liver cirrhosis. Journal of Clinical and Experimental Hepatology. 2015;5(3):p. 272. doi: 10.1016/j.jceh.2015.06.002. - DOI - PMC - PubMed
    1. Abbas N., Makker J., Abbas H., Balar B. Perioperative care of patients with liver cirrhosis: a review. Health Services Insights. 2017:G1–G12. - PMC - PubMed
    1. Mokdad A. A., Lopez A. D., Shahraz S. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine. 2014;12, article 145 doi: 10.1186/s12916-014-0145-y. - DOI - PMC - PubMed
    1. Safaei A., Oskouie A. A., Mohebbi S. R., et al. Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases. Gastroenterol Hepatol Bed Bench. 2016;9(3):G158–G173. - PMC - PubMed

MeSH terms